Citations

Clear

118 citation(s) found for "Bower, James".

Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism
Savica, Rodolfo , Bower, James H., Ahlskog, J. Eric , Graff‐Radford, Jonathan , Rocca, Walter A. , Grossardt, Brandon R. , Boeve, Bradley F. , Mielke, Michelle M.

Mayo Clinic

JAMA Neurology | May 15, 2017 | Volume: 74 | Issue: 7 | Pages: 839

10.1001/jamaneurol.2017.0603 | PMID 28505261 Get It

Incidence and time trends of drug‐induced parkinsonism: A 30‐year population‐based study
Savica, Rodolfo , Grossardt, Brandon R. , Bower, James H., Ahlskog, J. Eric , Rocca, Walter A. , Mielke, Michelle M. , Grossardt, Brandon R

Mayo Clinic

Movement Disorders | October 25, 2016 | Volume: 32 | Issue: 2 | Pages: 227-234

10.1002/mds.26839 | PMID 27779780 Get It

ABSTRACT Background Epidemiological studies of drug‐induced parkinsonism remain limited. Objectives To investigate the incidence and time trends of drug‐induced parkinsonism over 30 years in a geographically defined American population. Methods We used the medical records‐linkage system of the Rochester Epidemiology Project to identify all persons in Olmsted County, Minnesota, who received a screening diagnostic code for parkinsonism from 1976 through 2005. A movement disorders specialist reviewed the complete medical records of each person to confirm the presence of drug‐induced parkinsonism associated with dopamine‐blocking or dopamine‐depleting medications. Results Among 906 incident cases of parkinsonism from 1976 to 2005, 108 persons had drug‐induced parkinsonism (11.9%). The average annual incidence rate of drug‐induced parkinsonism was 3.3 per 100,000 person‐years, was higher in women, and increased with older age. Drug‐induced parkinsonism was the fifth‐most common type of parkinsonism overall; however, it was the most common type among persons younger than age 40 years. Typical antipsychotic drugs were the most common class of drugs associated with parkinsonism, whereas atypical antipsychotic drugs were rarely involved. The incidence rate of drug‐induced parkinsonism decreased 32.0% per decade (relative risk = 0.68; 95% confidence interval: 0.49–0.94) and 68.6% over the 30 years of the study. The decrease was similar in men (65.2%) and women (69.4%); however, the trend was significant only in women. Conclusions The incidence of drug‐induced parkinsonism increased with older age and was higher in women at all ages. Typical antipsychotic drugs were the most common cause. The incidence of drug‐induced parkinsonism decreased over the 30 years of the study because of changes in drug use. © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Time Trends in the Incidence of Parkinson Disease
Savica, Rodolfo , Grossardt, Brandon R. , Bower, James H., Ahlskog, J. Eric , Rocca, Walter A. , Grossardt, Brandon R

Mayo Clinic

JAMA Neurology | June 20, 2016 | Volume: 73 | Issue: 8 | Pages: 981

10.1001/jamaneurol.2016.0947 | PMID 27323276 Get It

Addressing neurologic needs in sub–Saharan Africa: An opportunity for multisociety cooperation
Bower, James H., Diop, Amadou Gallo, Gouider, Riadh , Schmutzhard, Erich

Mayo Clinic

Neurology | September 24, 2014 | Volume: 83 | Issue: 13 | Pages: 1207-1209

10.1212/wnl.0000000000000810 | PMID 25253876 Get It

Multiple system atrophy: Prognostic indicators of survival
Figueroa, Juan J., Parsaik, Ajay K. , Benarroch, Eduardo E. , Ahlskog, J. Eric , Fealey, Robert D., Parisi, Joseph E., Sandroni, Paola , Mandrekar, Jay , Iodice, Valeria , Low, Phillip A. , Bower, James H., Singer, Wolfgang

Mayo Clinic

Movement Disorders | June 7, 2014 | Volume: 29 | Issue: 9 | Pages: 1151-1157

10.1002/mds.25927 | PMID 24909319 Get It

AbstractNeurological and autonomic presentation in multiple system atrophy (MSA) may predict early mortality. Quantification of early autonomic failure as a mortality predictor is lacking. Early neurological and autonomic clinical features were retrospectively reviewed in 49 MSA cases (median age at onset, 56.1 years; 16 women) confirmed by autopsy at Mayo Clinic. When available, the 10‐point composite autonomic severity score derived from the autonomic reflex screen provided quantification of the degree of autonomic failure and thermoregulatory sweat test quantitated body surface anhidrosis. Symptoms at onset were autonomic in 50%, parkinsonian in 30%, and cerebellar in 20% of cases. Survival (median [95% confidence interval]) was 8.6 [6.7‐10.2] years. Survival was shorter in patients with early laboratory evidence of generalized (composite autonomic severity score ≥ 6) autonomic failure (7.0 [3.9‐9.8] vs. 9.8 [4.6‐13.8] years; P = 0.036), and early requirement of bladder catheterization (7.3 [3.1‐10.2] vs. 13.7 [8.5‐14.9] years; P = 0.003) compared with those without these clinical features. On Cox proportional analysis, prognostic indicators of shorter survival were older age at onset (hazard ratio [95% confidence interval], 1.04 [1.01‐1.08]; P = 0.03), early requirement of bladder catheterization (7.9 [1.88‐38.63]; P = 0.004), and early generalized (composite autonomic severity score ≥ 6) autonomic failure (2.8 [1.01‐9.26]; P = 0.047). Gender, phenotype, and early development of gait instability, aid‐requiring ambulation, orthostatic symptoms, neurogenic bladder, or significant anhidrosis (thermoregulatory sweat test ≥ 40%) were not indicators of shorter survival. Our data suggest that early development of severe generalized autonomic failure more than triples the risk of shorter survival in patients with MSA. © 2014 International Parkinson and Movement Disorder Society
When Drinking Makes the Tremor Worse: A Task‐Specific Orolingual Tremor
O’Gorman, Cullen , Bower, James H., Matsumoto, Joseph Y., Kantarci, Orhun H. , Kumar, Neeraj , O'Gorman, Cullen M, O'gorman, Cullen M

Mayo Clinic

Movement Disorders Clinical Practice | June 4, 2014 | Volume: 1 | Issue: 3 | Pages: 237-239

10.1002/mdc3.12041 | PMID 30363876 Get It

Improving the consent process for neuroepidemiologic research in resource-poor settings
Meta, Judith, Nasuwa, Fortunata , Mwendo, Emanuel, Reyburn, Hugh , Bower, James H.

Mayo Clinic

Neurology | March 10, 2014 | Volume: 82 | Issue: 10 | Pages: 895-897

10.1212/wnl.0000000000000184 | PMID 24616193 Get It

Creation of the AAN Global Health Section, Part II
Lee, Amy C., Chin, Jerome H. , Birbeck, Gretchen L. , Bower, James H., Meyer, Ana-Claire L.

Mayo Clinic

Neurology | June 3, 2013 | Volume: 80 | Issue: 23 | Pages: 2151-2153

10.1212/wnl.0b013e318295d6bc | PMID 23733551 Get It

Creation of the AAN Global Health Section, Part I
Lee, Amy C., Chin, Jerome H. , Birbeck, Gretchen L. , Bower, James H., Meyer, Ana-Claire

Mayo Clinic

Neurology | May 27, 2013 | Volume: 80 | Issue: 22 | Pages: 2062-2064

10.1212/wnl.0b013e318294b3b5 | PMID 23713085 Get It